Trial · NCT03199274
Adverse events18
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 18 of 18
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fever | General disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 4 | 52 | |
| other | Fever | General disorders | Group II (Standard of Care) | 0 | 52 | |
| other | Hives/rash | Skin and subcutaneous tissue disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 1 | 52 | |
| other | Hives/rash | Skin and subcutaneous tissue disorders | Group II (Standard of Care) | 0 | 52 | |
| other | Fatigue | General disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 1 | 52 | |
| other | Fatigue | General disorders | Group II (Standard of Care) | 0 | 52 | |
| other | Nausea | Gastrointestinal disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 2 | 52 | |
| other | Nausea | Gastrointestinal disorders | Group II (Standard of Care) | 2 | 52 | |
| other | Possible Seizure | Nervous system disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 0 | 52 | |
| other | Possible Seizure | Nervous system disorders | Group II (Standard of Care) | 1 | 52 | |
| other | Dyspnea | General disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 0 | 52 | |
| other | Dyspnea | General disorders | Group II (Standard of Care) | 1 | 52 | |
| other | Abdominal Pain | Gastrointestinal disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 1 | 52 | |
| other | Abdominal Pain | Gastrointestinal disorders | Group II (Standard of Care) | 1 | 52 | |
| other | Shoulder Pain | General disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 1 | 52 | |
| other | Shoulder Pain | General disorders | Group II (Standard of Care) | 0 | 52 | |
| other | Shortness of Breath | General disorders | Group I (Perflutren Protein-type A Microspheres, CEUS) | 1 | 52 | |
| other | Shortness of Breath | General disorders | Group II (Standard of Care) | 0 | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03199274/events